相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Intrahepatic cholangiocarcinoma: Tumour hetero- geneity and its clinical relevance
Mina Komuta
CLINICAL AND MOLECULAR HEPATOLOGY (2022)
Up-to-Date Pathologic Classification and Molecular Characteristics of Intrahepatic Cholangiocarcinoma
Taek Chung et al.
FRONTIERS IN MEDICINE (2022)
An immunostaining panel of C-reactive protein, N-cadherin, and S100 calcium binding protein P is useful for intrahepatic cholangiocarcinoma subtyping
Masayuki Akita et al.
HUMAN PATHOLOGY (2021)
Twelve years of SAMtools and BCFtools
Petr Danecek et al.
GIGASCIENCE (2021)
Profiling of conditionally reprogrammed cell lines for in vitro chemotherapy response prediction of pancreatic cancer
Hee Seung Lee et al.
EBIOMEDICINE (2021)
Conversion Therapy of Intrahepatic Cholangiocarcinoma Is Associated with Improved Prognosis and Verified by a Case of Patient-Derived Organoid
Zhiwei Wang et al.
CANCERS (2021)
Practical considerations in screening for genetic alterations in cholangiocarcinoma
T. S. Bekaii-Saab et al.
ANNALS OF ONCOLOGY (2021)
Molecular Characterization of Biliary Tract Cancer Predicts Chemotherapy and Programmed Death 1/Programmed Death-Ligand 1 Blockade Responses
Jihoon G. Yoon et al.
HEPATOLOGY (2021)
Patient-Derived Organoids of Cholangiocarcinoma
Christopher Fabian Maier et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Cholangiocarcinoma
Paul J. Brindley et al.
NATURE REVIEWS DISEASE PRIMERS (2021)
Risk factors for intrahepatic and extrahepatic cholangiocarcinoma: A systematic review and meta-analysis
Oliver Clements et al.
JOURNAL OF HEPATOLOGY (2020)
A phase III study of futibatinib (TAS-120) versus gemcitabine-cisplatin (gem-cis) chemotherapy as first-line (1L) treatment for patients (pts) with advanced (adv) cholangiocarcinoma (CCA) harboring fibroblast growth factor receptor 2 (FGFR2) gene rearrangements (FOENIX-CCA3).
Mitesh J. Borad et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
PROOF 302: A randomized, double-blind, placebo-controlled, phase III trial of infigratinib as adjuvant therapy in patients with invasive urothelial carcinoma harboring susceptible FGFR3 alterations.
Siamak Daneshmand et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
Molecular classification and therapeutic targets in extrahepatic cholangiocarcinoma
Robert Montal et al.
JOURNAL OF HEPATOLOGY (2020)
FIGHT-302: first-line pemigatinib vs gemcitabine plus cisplatin for advanced cholangiocarcinoma with FGFR2 rearrangements
Tanios S. Bekaii-Saab et al.
FUTURE ONCOLOGY (2020)
OIP5-AS1/miR-137/ZNF217 Axis Promotes Malignant Behaviors in Epithelial Ovarian Cancer
Linlin Guo et al.
CANCER MANAGEMENT AND RESEARCH (2020)
Cholangiocarcinoma 2020: the next horizon in mechanisms and management
Jesus M. Banales et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2020)
Anatomical, histomorphological and molecular classification of cholangiocarcinoma
Timothy Kendall et al.
LIVER INTERNATIONAL (2019)
Cholangiocarcinoma: Epidemiology and risk factors
Shahid A. Khan et al.
LIVER INTERNATIONAL (2019)
Probing the Tumor Suppressor Function of BAP1 in CRISPR-Engineered Human Liver Organoids
Benedetta Artegiani et al.
CELL STEM CELL (2019)
Establishment of Patient-Derived Organoids and Drug Screening for Biliary Tract Carcinoma
Yoshimasa Saito et al.
CELL REPORTS (2019)
Establishment and characterization of patient-derived organoids from a young patient with cervical clear cell carcinoma
Yoshiaki Maru et al.
CANCER SCIENCE (2019)
Establishment of an organoid bank of biliary tract and pancreatic cancers and its application for personalized therapy and future treatment
Yoshimasa Saito
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2019)
Histological and molecular characterization of intrahepatic bile duct cancers suggests an expanded definition of perihilar cholangiocarcinoma
Masayuki Akita et al.
HPB (2019)
Human primary liver cancer organoids reveal intratumor and interpatient drug response heterogeneity
Ling Li et al.
JCI INSIGHT (2019)
Genomic characterization of biliary tract cancers identifies driver genes and predisposing mutations
Christopher P. Wardell et al.
JOURNAL OF HEPATOLOGY (2018)
Induction of differentiation of intrahepatic cholangiocarcinoma cells to functional hepatocytes using an organoid culture system
Yoshimasa Saito et al.
SCIENTIFIC REPORTS (2018)
Organoid Models of Human Liver Cancers Derived from Tumor Needle Biopsies
Sandro Nuciforo et al.
CELL REPORTS (2018)
Maftools: efficient and comprehensive analysis of somatic variants in cancer
Anand Mayakonda et al.
GENOME RESEARCH (2018)
BAP1 acts as a tumor suppressor in intrahepatic cholangiocarcinoma by modulating the ERK1/2 and JNK/c-Jun pathways
Xu-Xiao Chen et al.
CELL DEATH & DISEASE (2018)
The critical role of the ZNF217 oncogene in promoting breast cancer metastasis to the bone
Aurelie Bellanger et al.
JOURNAL OF PATHOLOGY (2017)
Dichotomy in intrahepatic cholangiocarcinomas based on histologic similarities to hilar cholangiocarcinomas
Masayuki Akita et al.
MODERN PATHOLOGY (2017)
Human primary liver cancer-derived organoid cultures for disease modeling and drug screening
Laura Broutier et al.
NATURE MEDICINE (2017)
Whole-Genome and Epigenomic Landscapes of Etiologically Distinct Subtypes of Cholangiocarcinoma
Apinya Jusakul et al.
CANCER DISCOVERY (2017)
Distinct Clinicopathologic and Genetic Features of 2 Histologic Subtypes of Intrahepatic Cholangiocarcinoma
Akimasa Hayashi et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2016)
Culture and establishment of self-renewing human and mouse adult liver and pancreas 3D organoids and their genetic manipulation
Laura Broutier et al.
NATURE PROTOCOLS (2016)
Enrichr: a comprehensive gene set enrichment analysis web server 2016 update
Maxim V. Kuleshov et al.
NUCLEIC ACIDS RESEARCH (2016)
The Ensembl Variant Effect Predictor
William McLaren et al.
GENOME BIOLOGY (2016)
Morphological subclassification of intrahepatic cholangiocarcinoma: etiological, clinicopathological, and molecular features
Jau-Yu Liau et al.
MODERN PATHOLOGY (2014)
Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2
Michael I. Love et al.
GENOME BIOLOGY (2014)
STAR: ultrafast universal RNA-seq aligner
Alexander Dobin et al.
BIOINFORMATICS (2013)
Enrichr: interactive and collaborative HTML5 gene list enrichment analysis tool
Edward Y. Chen et al.
BMC BIOINFORMATICS (2013)
ZNF217 Is a Marker of Poor Prognosis in Breast Cancer That Drives Epithelial-Mesenchymal Transition and Invasion
Julie A. Vendrell et al.
CANCER RESEARCH (2012)
S100P immunostaining identifies a subset of peripheral-type intrahepatic cholangiocarcinomas with morphological and molecular features similar to those of perihilar and extrahepatic cholangiocarcinomas
Jia-Huei Tsai et al.
HISTOPATHOLOGY (2012)
The Transcription Factor ZNF217 Is a Prognostic Biomarker and Therapeutic Target during Breast Cancer Progression
Laurie E. Littlepage et al.
CANCER DISCOVERY (2012)
RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome
Bo Li et al.
BMC BIOINFORMATICS (2011)
ZNF217 confers resistance to the pro-apoptotic signals of paclitaxel and aberrant expression of Aurora-A in breast cancer cells
Aurelie Thollet et al.
MOLECULAR CANCER (2010)
Differential expression analysis for sequence count data
Simon Anders et al.
GENOME BIOLOGY (2010)
ZNF217 suppresses cell death associated with chemotherapy and telomere dysfunction
GQ Huang et al.
HUMAN MOLECULAR GENETICS (2005)
分享论文
